An Evaluation Of West Pharmaceutical Services, Inc (NYSE: WST) Prospects

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

WST belongs to the Healthcare sector of the NYSE while operating in the Medical Instruments & Supplies industry. The current market capitalization of West Pharmaceutical Services, Inc is $24.32B. A total of 2.44 million shares were traded on the day, compared to an average of 607.77K shares.

In the most recent transaction, Witherspoon Charles sold 703 shares of WST for 310.40 per share on Oct 29 ’24. After the transaction, the VP & Treasurer now owns 1,253 company shares. In a previous transaction on Aug 19 ’24, Witherspoon Charles sold 1,029 shares at 300.00 per share. WST shares that VP & Treasurer owns now total 1,478.

Among the insiders who sold shares, Hofmann Thomas W disposed of 617 shares on May 10 ’24 at a per-share price of $365.92. This resulted in the Director holding 43,565 shares of WST after the transaction. In another insider transaction, Green Eric Mark sold 30,732 shares at $304.71 per share on Aug 06 ’24. Company shares held by the President, CEO and Board Chair now total 161,898.

Dividend

Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. West Pharmaceutical Services, Inc pays an annual dividend of $0.81, resulting in a dividend yield of 0.24%, and it has a price to earnings (P/E) ratio of 49.16. WST’s most recent ex-dividend date was 0.25% when it declared a $0.21 quarterly dividend that was paid in cash on 11/13/2024. Previously, the company paid the dividend on 7/31/2024 with an ex-dividend date of 0.22%. The WST stock dividend was $0.20 per share in cash.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, WST has a high of $413.70 and a low of $265.00.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. WST’s latest balance sheet shows that the firm has $762.60M in Cash & Short Term Investments as of fiscal 2021. There were $325.30M in debt and $594.10M in liabilities at the time. Its Book Value Per Share was $37.96, while its Total Shareholder’s Equity was $2.34B.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for WST is Buy with a score of 4.56.

Most Popular

Related Posts